The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
ProMetic Life Sciences Inc (TSX:PLI) announced that it has a net profit of $1.0million for the fourth quarter and an annual revenue of $23.3 million which is 32% higher than the previous year.
ProMetic Life Sciences Inc (TSX:PLI) announced that it has a net profit of $1.0million for the fourth quarter and an annual revenue of $23.3 million which is 32% higher than the previous year.
As quoted in the press release:
2012 was a record year for ProMetic with the highest annual sales in our corporate history. 2012 was also a pivotal year in terms of closing new strategic partnerships and alliances in both established and emerging markets. We are proud to have exceeded our corporate objectives set for the year and look forward to a strong 2013 as we continue to position ProMetic’s technologies as new industry standards”, stated Mr. Pierre Laurin, ProMetic’s President and Chief Executive Officer. “We believe that the necessary foundation to achieve the next stage of corporate growth has been firmly established for 2013 and the coming years”, added Mr. Laurin.
Click here to read the full ProMetic Life Sciences Inc (TSX:PLI) press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.